Healthcare advocates call for universal coverage, acknowledge challenges

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 18 No 7
Volume 18
Issue 7

Washington, DC-The idea of universal healthcare coverage was a crowd pleaser at the 2009 Annual Advocacy Training Conference of the National Breast Cancer Coalition, but expert panelists agreed that making that dream into a reality will take time and perseverance.

Washington, DC-The idea of universal healthcare coverage was a crowd pleaser at the 2009 Annual Advocacy Training Conference of the National Breast Cancer Coalition, but expert panelists agreed that making that dream into a reality will take time and perseverance.

At an NBCC plenary session, participants compared the attempted reform of the health system during the administration of President Bill Clinton to the current situation.

“We’re in the same position today that we were then, but some things are different now. President Obama is much more popular than Mr. Clinton was, and major stakeholders are in a more powerful position than they were 15 years ago,” said session moderator Joanne Howes, a women’s health policy consultant and a partner with DDB Issues & Advocacy.

Women are some of those major stakeholders now, said Cindy Pearson, executive director of the National Women’s Health Network. Women have been responsible for most of the public health gains in this country, such as the promotion of breast cancer screening and clinical trial recruitment.

Obviously, more public participation is needed. Carmella Bocchino, executive vice president of clinical affairs and strategic planning at America’s Health Insurance Plans, said that consumers must be part of the debate on healthcare reform. “President Barack Obama has laid out an eight-pillar plan for change and he knows that tackling cost containment has to be the first order of business,” she said.

However, Judith Feder, PhD, a professor of public policy at the Georgetown Public Policy Institute in Washington, DC, warned that healthcare reform cannot be so drastic that it frightens consumers. “To truly change the system, emphasis should be placed on prevention, on rewarding good care, and providing only necessary care. Consumers understand these things but are reluctant to practice them,” she said.

Jeffrey Levi, executive director of the Trust for America’s Health, said that he believes the most important elements of President Obama’s eight pillars are health IT, comparative effectiveness of health research, and community level prevention. “However, if bills to achieve these goals are perceived as too expensive, they won’t be passed,” he cautioned.

Recent Videos
Heather Zinkin, MD, states that reflexology improved pain from chemotherapy-induced neuropathy in patients undergoing radiotherapy for breast cancer.
Study findings reveal that patients with breast cancer reported overall improvement in their experience when receiving reflexology plus radiotherapy.
Patients undergoing radiotherapy for breast cancer were offered 15-minute nurse-led reflexology sessions to increase energy and reduce stress and pain.
Whole or accelerated partial breast ultra-hypofractionated radiation in older patients with early breast cancer may reduce recurrence with low toxicity.
Ultra-hypofractionated radiation in those 65 years or older with early breast cancer yielded no ipsilateral recurrence after a 10-month follow-up.
The unclear role of hypofractionated radiation in older patients with early breast cancer in prior trials incentivized research for this group.
Patients with HR-positive, HER2-positive breast cancer and high-risk features may derive benefit from ovarian function suppression plus endocrine therapy.
Paolo Tarantino, MD discusses updated breast cancer trial findings presented at ESMO 2024 supporting the use of agents such as T-DXd and ribociclib.
Paolo Tarantino, MD, discusses the potential utility of agents such as datopotamab deruxtecan and enfortumab vedotin in patients with breast cancer.
Paolo Tarantino, MD, highlights strategies related to screening and multidisciplinary collaboration for managing ILD in patients who receive T-DXd.